Equillium logo

Equillium share price today

(EQ)

Equillium share price is $0.65 & ₹55.38 as on 25 Dec 2024, 2.30 'hrs' IST

$0.65

0.05

(7.99%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Equillium share price in Dollar and Rupees. Guide to invest in Equillium from India. Also see the sentimental analysis on Indian investors investing in Equillium. Get details on the Indian mutual funds that are investing in Equillium. Get Analyst recommendations and forecasts along with all the Equillium's financials.

Equillium share price movements

  • Today's Low: $0.60
    Today's High: $0.65

    Day's Volatility :7.69%

  • 52 Weeks Low: $0.56
    52 Weeks High: $3.25

    52 Weeks Volatility :82.75%

Equillium Returns

PeriodEquillium IncIndex (Russel 2000)
3 Months
-18.25%
0.0%
6 Months
-3.32%
0.0%
1 Year
-0.81%
0.0%
3 Years
-84.29%
-21.1%

Equillium Key Statistics

in dollars & INR

Previous Close
$0.598
Open
$0.6
Today's High
$0.65
Today's Low
$0.6
Market Capitalization
$22.9M
Today's Volume
$108.7K
52 Week High
$3.25
52 Week Low
$0.5605
Revenue TTM
$42.6M
EBITDA
$-9.6M
Earnings Per Share (EPS)
$-0.12
Profit Margin
-19.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-33.67%

How to invest in Equillium from India?

It is very easy for Indian residents to invest directly in Equillium from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Equillium stock in both Indian Rupees (INR) and US Dollars (USD). Search for Equillium or EQ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Equillium or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Equillium shares which would translate to 1.311 fractional shares of Equillium as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Equillium, in just a few clicks!

Returns in Equillium for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Equillium investment value today

Current value as on today

₹1,02,239

Returns

₹2,239

(+2.24%)

Returns from Equillium Stock

₹0 (0%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Equillium

58%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Equillium on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 58% more investors are searching Equillium in the last 30 days versus the previous period.

Global Institutional Holdings in Equillium

  • Decheng Capital LLC

    12.55%

  • Vanguard Group Inc

    2.38%

  • Cota Capital Management, LLC

    1.59%

  • Renaissance Technologies Corp

    0.91%

  • Geode Capital Management, LLC

    0.58%

  • Callan Capital, LLC

    0.28%

Analyst Recommendation on Equillium

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Equillium(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Equillium

What analysts predicted

Upside of 412.82%

Current:

$0.65

Target:

$3.33

Insights on Equillium

  • Price Movement

    In the last 7 days, EQ stock has moved up by 7.6%
  • EQ vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 25.3%
  • EQ vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 110.8%
  • Price to Sales

    ForEQ every $1 of sales, investors are willing to pay $0.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Equillium Technicals Summary

Sell

Neutral

Buy

Equillium is currently in a neutral trading position according to technical analysis indicators.

Equillium Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Equillium Inc
-17.19%
-3.32%
-0.81%
-84.29%
-84.59%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Equillium Inc
NA
NA
NA
-0.16
-0.34
-0.12
NA
0.64
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Equillium Inc
Buy
$22.9M
-84.59%
NA
-19.51%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Equillium

equillium, inc., a clinical-stage biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor cd6, which is in phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and phase 1 clinical trial for the treatment of asthma and lupus nephritis. the company was formerly known as attenuate biopharmaceuticals, inc. and changed its name to equillium, inc. in may 2017. equillium, inc. was founded in 2017 and is headquartered in la jolla, california.
Organization
Equillium
Employees
45
CEO
Mr. Daniel Mark Bradbury
Industry
Health Technology

Management People of Equillium

NameTitle
Mr. Daniel Mark Bradbury
Executive Chairman
Mr. Bruce D. Steel C.F.A.
Co-Founder, President, CEO & Director
Ms. Christine Zedelmayer M.B.A., P.M.P.
Senior VP & COO
Dr. Stephen Connelly Ph.D.
Chief Scientific Officer & Director
Mr. Jason A. Keyes
Chief Financial Officer
Penny Tom
Senior VP of Finance & Principal Accounting Officer
Mr. Michael Moore
Vice President of Investor Relations & Corporate Communications
Dr. Matthew Ritter Ph.D.
Senior Vice President of Corporate Development
Mr. Joel M. Rothman
Chief Development Officer

Important FAQs about investing in Equillium from India :

What is Equillium share price today?

Equillium share price today stands at $0.65, Open: $0.60 ; Previous Close: $0.60 ; High: $0.65 ; Low: $0.60 ; 52 Week High: $3.25 ; 52 Week Low: $0.56. The stock opens at $0.60, after a previous close of $0.60. The stock reached a daily high of $0.65 and a low of $0.60, with a 52-week high of $3.25 and a 52-week low of $0.56.

Can Indians buy Equillium shares?

Yes, Indians can invest in the Equillium (EQ) from India.

With INDmoney, you can buy Equillium at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Equillium at zero transaction cost.

How can I buy Equillium shares from India?

It is very easy to buy Equillium from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Equillium be purchased?

Yes, you can buy fractional shares of Equillium with INDmoney app.

What are the documents required to start investing in Equillium stocks?

To start investing in Equillium, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Equillium

Today’s highest price of Equillium (EQ) is $0.65.

Today’s lowest price of Equillium (EQ) is $0.60.

What is today's market capitalisation of Equillium

Today's market capitalisation of Equillium EQ is 22.9M

What is the 52 Week High and Low Range of Equillium

  • 52 Week High

    $3.25

  • 52 Week Low

    $0.56

What are the historical returns of Equillium?

  • 1 Month Returns

    -17.19%

  • 3 Months Returns

    -3.32%

  • 1 Year Returns

    -0.81%

  • 5 Years Returns

    -84.59%

Who is the Chief Executive Officer (CEO) of Equillium

Mr. Daniel Mark Bradbury is the current Chief Executive Officer (CEO) of Equillium.